Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
5 papers
Recent·Most cited
M. McCallum, N. Czudnochowski, L. E. Rosen…·D. Veesler
This study determines the structural basis of SARS-CoV-2 Omicron's immune evasion and receptor engagement through cryo-EM and X-ray crystal structures of the spike and RBD bound to antibodies and ACE2.
E. Cameroni, C. Saliba, J. E. Bowen…·P
This study shows that Omicron variant's spike protein has enhanced ACE2 binding and reduces neutralizing activity, but some broadly neutralizing antibodies remain effective.
Y.-J. Park, A. De Marco, T. N. Starr…·D. Veesler
This study identifies a broadly neutralizing antibody against sarbecoviruses that targets the ACE2 binding site and shows high resistance to escape mutations.
T. N. Starr, S. K. Zepeda, A. C. Walls…·J. D. Bloom
This study traces the evolutionary history of ACE2 binding in sarbecoviruses, finding it is an ancestral trait that has been lost in some clades and is highly evolvable through single amino-acid mutations.
A. C. Walls, M. C. Miranda, M. N. Pham…·Veesler
This study shows that a SARS-CoV-2 RBD nanoparticle vaccine protects against SARS-CoV-2 and related sarbecoviruses, including variants, in mice and non-human primates.